![Sean Cao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Cao
Corporate Officer/Principal chez
NOVABRIDGE BIOSCIENCES
Fortune : 28 053 $ au 31/05/2026
Profil
Dr. Sean W.
Cao is a Chief Business Development Officer at NovaBridge Biosciences and a Chief Executive Officer at Abio-X Holdings, Inc. He is on the Board of Directors at CBC Group (Singapore) Pte.
Ltd. and NiKang Therapeutics, Inc. Dr. Cao was previously employed as a CEO & Co-founder by Everest Medicines Ltd., an Associate by New Leaf Venture Partners LLC, a Manager-Product Development by Johnson & Johnson, a Senior Research Investigator by Sanofi-Aventis U.S.
LLC, and a Chief Executive Officer & Director by ENSEM Therapeutics, Inc. He also served on the board at Aureon Laboratories, Inc. He received his MBA from the University of Pennsylvania, a doctorate degree from Nankai University and a doctorate degree from the University of Virginia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/06/2026 | 35 073 ( 0,02% ) | 28 053 $ | 31/05/2026 |
Postes actifs de Sean Cao
| Sociétés | Poste | Début |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Corporate Officer/Principal | 03/09/2025 |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule oncology medicines to help patients | Directeur/Membre du Conseil | - |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Directeur/Membre du Conseil | 01/10/2016 |
Abio-X Holdings, Inc. | Directeur Général | - |
Anciens postes connus de Sean Cao
| Sociétés | Poste | Fin |
|---|---|---|
ENSEM Therapeutics, Inc.
 ENSEM Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops molecule precision medicines for oncology | Directeur Général | 05/06/2023 |
| EVEREST MEDICINES LIMITED | Directeur Général | 01/02/2020 |
Aureon Biosciences, Inc.
 Aureon Biosciences, Inc. BiotechnologyHealth Technology Develops predictive tests for cancer recurrence and provides contract research services | Directeur/Membre du Conseil | 01/03/2010 |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Analyste en capital-investissement | 01/09/2009 |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Analyste en capital-investissement | 31/08/2009 |
Formation de Sean Cao
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Aureon Biosciences, Inc.
Aureon Biosciences, Inc. BiotechnologyHealth Technology Develops predictive tests for cancer recurrence and provides contract research services | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
Nankai University
 Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
CBC Group (Singapore) Pte. Ltd.
CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group invests in middle market companies located in China. The firm focuses on pharmaceutical, biotechnology, medical technology and healthcare service sectors. It provides financing in the form of equity, debt and non-dilutive financing for for buyout, growth, royalty acquisitions, structured transactions and hybrid financings. It acquires controlling stake in the company. | Finance |
Everest Medicines Ltd.
 Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule oncology medicines to help patients | Health Technology |
ENSEM Therapeutics, Inc.
ENSEM Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops molecule precision medicines for oncology | Health Technology |
Abio-X Holdings, Inc. |
